AMRI CEO diverts bonus to employees, charity; PGXL and Silicon team up for CRO service;

> PGXL and Silicon Biosystems are joining forces to offer CRO services using the latter's DEPArray biomarker discovery platform. News

> AMRI's ($AMRI) Thomas D'Ambra pulled in $3.8 million last year but declined his bonus, asking it to go instead to his employees and charity. Article

> DSM has launched a biologics facility in Australia with the help of the local government. Item

> Pharma contractor AmerisourceBergen ($ABC) posted revenue of $20.5 billion last quarter, but spiking costs slashed profit by about 79% to $45 million. Story

> CMO Fujifilm has expanded its biologics manufacturing capabilities in the U.K. Report

Suggested Articles

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.

After three full business days in the position, an abrupt about-face has LabCorp Diagnostics’ CEO John Ratliff heading for the exit.

The initiative will see Evotec mine a kidney biobank for new renal therapy targets before the joint venture out-licenses resulting assets to Vifor.